Neuren posts bumper sales in latest release to market
SYDNEY: Neuren Pharmaceuticals (ASX:NEU) shares should be worth more than double their current soft valuation,
SYDNEY: Neuren Pharmaceuticals (ASX:NEU) shares should be worth more than double their current soft valuation,